Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.


Thai teen kills 7 in rampage at home and school before shooting himself
US appeals court blocks Trump’s $400 million White House ballroom project
Spain dismantles one of Mediterranean's largest human smuggling networks
Syria says bomb on minibus near Damascus wounded 14, deaths reported mistakenly
Spain hopes to transfer migrant minors to mainland within weeks
